Guiraud S, Aartsma-Rus A, Vieira NM, Davies KE, van Ommen GJ, Kunkel LM. The pathogenesis and therapy of muscular dystrophies. Annu Rev Genomics Hum Genet. 2015;16:281–308.
Article
CAS
PubMed
Google Scholar
Mendell JR, Shilling C, Leslie ND, Flanigan KM, Al-Dahhak R, Gastier-Foster J, et al. Evidence-based path to newborn screening for Duchenne muscular dystrophy. Ann Neurol. 2012;71:304–13.
Article
CAS
PubMed
Google Scholar
Multiple authors. Experimental primary myopathies and their relationship to human disease. Ann NY Acad Sci. 1966;138:3–366.
Google Scholar
Rowland LP. Biochemistry of muscle membranes in Duchenne muscular dystrophy. Muscle Nerve. 1980;3:3–20.
Article
CAS
PubMed
Google Scholar
Dreyfus JC, Schapii-a G, Schapira I. Biochemical study of muscle in progressive muscular dystrophy. J Clin Invest. 1954;33:794–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Okinaka S, Kumagai H, Ebashi S, Sugita H, Momoi H, Toyokura Y, et al. Serum creatine phosphokinase. Activity in progressive muscular dystrophy and neuromuscular diseases. Arch Neurol. 1961;4:520–5.
Article
CAS
PubMed
Google Scholar
Munsat TL, Baloh R, Pearson CM, Fowler Jr W. Serum enzyme alterations in neuromuscular disorders. JAMA. 1973;226:1536–43.
Article
CAS
PubMed
Google Scholar
Schmalbruch H. Segmental fibre breakdown and defects of the plasmalemma in diseased human muscles. Acta Neuropathol. 1975;33:129–41.
Article
CAS
PubMed
Google Scholar
Mokri B, Engel AG. Duchenne dystrophy: electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber. Neurology. 1975;25:1111–20.
Article
CAS
PubMed
Google Scholar
Pestronk A, Parhad IM, Drachman DB, Price DL. Membrane myopathy: morphological similarities to Duchenne muscular dystrophy. Muscle Nerve. 1982;5:209–14.
Article
CAS
PubMed
Google Scholar
Carpenter S, Karpati G. Duchenne muscular dystrophy: plasma membrane loss initiates muscle cell necrosis unless it is repaired. Brain. 1979;102:147–61.
Article
CAS
PubMed
Google Scholar
Buchthal F, Rosenfalck P. Electrophysiologic aspects of myopathy with particular reference to progressive muscular dystrophy. In: Bourne GH, Golarz MN, editors. Muscular dystrophy in man and animals. New York: Hafner Publishing Company; 1963. p. 193–243.
Google Scholar
Desmedt JE, Borenstein S. Regeneration in Duchenne muscular dystrophy. Electromyographic evidence. Arch Neurol. 1976;33:642–50.
Article
CAS
PubMed
Google Scholar
Emeryk-Szajewska B, Kopeć J. Electromyographic pattern in Duchenne and Becker muscular dystrophy. Part II. Electromyographic pattern in Becker muscular dystrophy in comparison with Duchenne muscular dystrophy. Electromyogr Clin Neurophysiol. 2008;48:279–84.
CAS
PubMed
Google Scholar
Ishpekova B, Milanov I, Christova LG, Alexandrov AS. Comparative analysis between Duchenne and Becker types muscular dystrophy. Electromyogr Clin Neurophysiol. 1999;39:315–8.
CAS
PubMed
Google Scholar
Hehir MK, Logigian EL. Electrodiagnosis of myotonic disorders. Phys Med Rehabil Clin N Am. 2013;24:209–20.
Article
PubMed
Google Scholar
AANEM. Glossary of terms in neuromuscular & electrodiagnostic medicine. Muscle Nerve. 2015;52 Suppl 2:145–203.
Google Scholar
Fellows LK, Foster BJ, Chalk CH. Clinical significance of complex repetitive discharges: a case-control study. Muscle Nerve. 2003;28:504–7.
Article
PubMed
Google Scholar
Georgesco M, Salerno A. Spontaneous electromyographic activity. Practical importance. Neurophysiol Clin. 2000;30:289–305.
Article
CAS
PubMed
Google Scholar
Partanen JV. Ephaptic transmission from type ii afferents to static γ and β efferents causes complex repetitive discharge: an hypothesis. Muscle Nerve. 2016;53:508–12.
Article
CAS
PubMed
Google Scholar
Franke C, Hatt H, Iaizzo PA, Lehmann-Horn F. Characteristics of Na+ channels and Cl-conductance in resealed muscle fibre segments from patients with myotonic dystrophy. J Physiol. 1990;425:391–405.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hirn C, Shapovalov G, Petermann O, Roulet E, Ruegg UT. Nav1.4 deregulation in dystrophic skeletal muscle leads to Na+ overload and enhanced cell death. J Gen Physiol. 2008;132:199–208.
Article
CAS
PubMed
PubMed Central
Google Scholar
Han JJ, Carter GT, Ra JJ, Abresch RT, Chamberlain JS, Robinson LR. Electromyographic studies in mdx and wild-type C57 mice. Muscle Nerve. 2006;33:208–14.
Article
PubMed
Google Scholar
Carter GT, Longley KJ, Entrikin RK. Electromyographic and nerve conduction studies in the mdx mouse. Am J Phys Med Rehabil. 1992;71:2–5.
Article
CAS
PubMed
Google Scholar
Walton JN. On the inheritance of muscular dystrophy. Ann Hum Genet. 1955;20:1–13.
Article
CAS
PubMed
Google Scholar
Milhorat AT, Wolff HG. Studies in diseases of muscle: XII. Heredity of progressive muscular dystrophy; relationship between age at onset of symptoms and clinical course. Arch Neurol Psychiatry. 1943;49:641–54.
Article
Google Scholar
Gardner-Medwin D, Johnston HM. Severe muscular dystrophy in girls. J Neurol Sci. 1984;64:79–87.
Article
CAS
PubMed
Google Scholar
Soltanzadeh P, Friez MJ, Dunn D, von Niederhausern A, Gurvich OL, Swoboda KJ, et al. Clinical and genetic characterization of manifesting carriers of DMD mutations. Neuromuscul Disord. 2010;20:499–504.
Article
PubMed
PubMed Central
Google Scholar
Boyd Y, Buckle V, Holt S, Munro E, Hunter D, Craig I. Muscular dystrophy in girls with X; autosome translocations. J Med Genet. 1986;23:484–90.
Article
CAS
PubMed
PubMed Central
Google Scholar
Davies KE, Pearson PL, Harper PS, Murray JM, O’Brien T, Sarfarazi M, et al. Linkage analysis of two cloned DNA sequences flanking the Duchenne muscular dystrophy locus on the short arm of the human X chromosome. Nucleic Acids Res. 1983;11:2303–12.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kingston HM, Thomas NS, Pearson PL, Sarfarazi M, Harper PS. Genetic linkage between Becker muscular dystrophy and a polymorphic DNA sequence on the short arm of the X chromosome. J Med Genet. 1983;20:255–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kunkel LM, Monaco AP, Middlesworth W, Ochs HD, Latt SA. Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion. Proc Natl Acad Sci U S A. 1985;82:4778–82.
Article
CAS
PubMed
PubMed Central
Google Scholar
Francke U, Ochs HD, de Martinville B, Giacalone J, Lindgren V, Distèche C, et al. Minor Xp21 chromosome deletion in a male associated with expression of Duchenne muscular dystrophy, chronic granulomatous disease, retinitis pigmentosa, and McLeod syndrome. Am J Hum Genet. 1985;37:250–67.
CAS
PubMed
PubMed Central
Google Scholar
Kunkel LM, Hejtmancik JF, Caskey CT, Speer A, Monaco AP, Middlesworth W, et al. Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature. 1986;322:73–7.
Article
CAS
PubMed
Google Scholar
Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell. 1987;50:509–17.
Article
CAS
PubMed
Google Scholar
Hoffman EP, Brown Jr RH, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987;51:919–28.
Article
CAS
PubMed
Google Scholar
Monaco AP, Bertelson CJ, Liechti-Gallati S, Moser H, Kunkel LM. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics. 1988;2:90–5.
Article
CAS
PubMed
Google Scholar
Prior TW, Bridgeman SJ. Experience and strategy for the molecular testing of Duchenne muscular dystrophy. J Mol Diagn. 2005;7:317–26.
Article
CAS
PubMed
PubMed Central
Google Scholar
Traverso M, Malnati M, Minetti C, Regis S, Tedeschi S, Pedemonte M, et al. Multiplex real-time PCR for detection of deletions and duplications in dystrophin gene. Biochem Biophys Res Commun. 2006;339:145–50.
Article
CAS
PubMed
Google Scholar
Flanigan KM, Dunn DM, von Niederhausern A, Soltanzadeh P, Gappmaier E, Howard MT, et al. Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort. Hum Mutat. 2009;30:1657–66.
Article
CAS
PubMed
PubMed Central
Google Scholar
Flanigan KM. Duchenne and Becker muscular dystrophies. Neurol Clin. 2014;32:671–88.
Article
PubMed
Google Scholar
Miskew Nichols B, Aoki Y, Kuraoka M, Lee JJ, Takeda S, Yokota T. Multi-exon skipping using cocktail antisense oligonucleotides in the canine X-linked muscular dystrophy. J Vis Exp. 2016;24:111.
Google Scholar
Campbell KP, Kahl SD. Association of dystrophin and an integral membrane glycoprotein. Nature. 1989;338:259–62.
Article
CAS
PubMed
Google Scholar
Cohn RD, Campbell KP. Molecular basis of muscular dystrophies. Muscle Nerve. 2000;23:1456–71.
Article
CAS
PubMed
Google Scholar
Ervasti JM. Dystrophin, its interactions with other proteins, and implications for muscular dystrophy. Biochim Biophys Acta. 2007;1772:108–17.
Article
CAS
PubMed
Google Scholar
Witkowski JA. Review article: dystrophin-related muscular dystrophies. J Child Neurol. 1989;4:251–71.
Article
CAS
PubMed
Google Scholar
Dubowitz V. Review article: the Duchenne dystrophy story: from phenotype to gene and potential treatment. J Child Neurol. 1989;4:240–50.
Article
CAS
PubMed
Google Scholar
Lewis J. Between the lines: a message of hope. J Child Neurol. 1989;4:272–3.
Article
CAS
PubMed
Google Scholar
Shieh PB. Duchenne muscular dystrophy: clinical trials and emerging tribulations. Curr Opin Neurol. 2015;28:542–6.
Article
CAS
PubMed
Google Scholar
Straub V, Balabanov P, Bushby K, Ensini M, Goemans N, De Luca A, et al. Stakeholder cooperation to overcome challenges in orphan medicine development: the example of Duchenne muscular dystrophy. Lancet Neurol. 2016;15:882–90.
Article
PubMed
Google Scholar
Arrowsmith J. Trial watch: Phase II failures: 2008-2010. Nat Rev Drug Discov. 2011;10:328–9.
Article
CAS
PubMed
Google Scholar
Arrowsmith J, Miller P. Trial watch: phase II and phase III attrition rates 2011-2012. Nat Rev Drug Discov. 2013;12:569.
Article
CAS
PubMed
Google Scholar
Carlisle B, Kimmelman J, Ramsay T, MacKinnon N. Unsuccessful trial accrual and human subjects protections: an empirical analysis of recently closed trials. Clin Trials. 2015;12:77–83.
Article
PubMed
Google Scholar
Milne CP. Prospects for rapid advances in the development of new medicines for special medical needs. Clin Pharmacol Ther. 2014;95:98–109.
Article
PubMed
Google Scholar
Bushby K, Finkel R, Wong B, Barohn R, Campbell C, Comi GP, et al. Ataluren treatment of patients with nonsense mutation dystrophinopathy. Muscle Nerve. 2014;50:477–87.
Article
CAS
PubMed
Google Scholar
Haas M, Vlcek V, Balabanov P, Salmonson T, Bakchine S, Markey G, et al. European Medicines Agency review of ataluren for the treatment of ambulant patients aged 5 years and older with Duchenne muscular dystrophy resulting from a nonsense mutation in the dystrophin gene. Neuromuscul Disord. 2015;25:5–13.
Article
PubMed
Google Scholar
Witting N, Kruuse C, Nyhuus B, Prahm KP, Citirak G, Lundgaard SJ, et al. Effect of sildenafil on skeletal and cardiac muscle in Becker muscular dystrophy. Ann Neurol. 2014;76:550–7.
Article
CAS
PubMed
Google Scholar
Leung DG, Herzka DA, Thompson WR, He B, Bibat G, Tennekoon G, et al. Sildenafil does not improve cardiomyopathy in Duchenne/Becker muscular dystrophy. Ann Neurol. 2014;76:541–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Editorial. Railroading at the FDA. Nature Biotech. 2016;34:1078.
Article
CAS
Google Scholar
Syed YY. Eteplirsen: first global approval. Drugs. 2016;2 [Epub ahead of print].
Jacobs AC, Hatfield KP. History of chronic toxicity and animal carcinogenicity studies for pharmaceuticals. Vet Pathol. 2013;50:324–33.
Article
CAS
PubMed
Google Scholar
Lehman AJ, Patterson WI, Davidow B, Hagan EC, Woodard G, Laug EP, et al. Procedures for the appraisal of the toxicity of chemicals in foods, drugs and cosmetics. Food Drug Cosmet Law J. 1955;10:679–748.
CAS
Google Scholar
Bailey GP, Mariën D. The value of juvenile animal studies “What have we learned from preclinical juvenile toxicity studies? II”. Birth Defects Res B Dev Reprod Toxicol. 2011;92:273–91.
Article
CAS
PubMed
Google Scholar
Bailey AM, Mendicino M, Au P. An FDA perspective on preclinical development of cell-based regenerative medicine products. Nat Biotechnol. 2014;32:721–3.
Article
CAS
PubMed
Google Scholar
Bailey AM, Arcidiacono J, Benton KA, Taraporewala Z, Winitsky S. United States food and drug administration regulation of gene and cell therapies. Adv Exp Med Biol. 2015;871:1–29.
Article
PubMed
Google Scholar
National Research Council. Models for biomedical research. A new perspective. Washington, DC: The National Academy Press; 1985.
Google Scholar
Bulfield G, Siller WG, Wight PAL, Moore KJ. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci U S A. 1984;81:1189–92.
Article
CAS
PubMed
PubMed Central
Google Scholar
Manning J, O’Malley D. What has the mdx mouse model of Duchenne muscular dystrophy contributed to our understanding of this disease? J Muscle Res Cell Motil. 2015;36:155–67.
Article
CAS
PubMed
Google Scholar
Sicinski P, Geng Y, Ryder-Cook AS, Barnard EA, Darlison MG, Barnard PJ. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science. 1989;244:1578–80.
Article
CAS
PubMed
Google Scholar
Brinkmeyer-Langford C, Kornegay JN. Comparative genomics of X-linked muscular dystrophies: the golden retriever model. Curr Genomics. 2013;14:330–42.
Article
CAS
PubMed
PubMed Central
Google Scholar
Carpenter JL, Hoffman EP, Romanul FC, Kunkel LM, Rosales RK, Ma NS, et al. Feline muscular dystrophy with dystrophin deficiency. Am J Pathol. 1989;135:909–19.
CAS
PubMed
PubMed Central
Google Scholar
Gaschen FP, Hoffman EP, Gorospe JR, Uhl EW, Senior DF, Cardinet 3rd GH, et al. Dystrophin deficiency causes lethal muscle hypertrophy in cats. J Neurol Sci. 1992;110:149–59.
Article
CAS
PubMed
Google Scholar
Selsby JT, Ross JW, Nonneman D, Hollinger K. Porcine models of muscular dystrophy. ILAR J. 2015;56:116–26.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gaschen F, Gaschen L, Seiler G, Welle M, Jaunin VB, Jmaa DG, et al. Lethal peracute rhabdomyolysis associated with stress and general anesthesia in three dystrophin-deficient cats. Vet Pathol. 1998;35:117–23.
Article
CAS
PubMed
Google Scholar
Kornegay JN, Childers MK. Canine inherited dystrophinopathies and centronuclear myopathies. In: Childers MK, editor. Regenerative medicine for degenerative muscle diseases. Series title: stem cell biology and regenerative medicine. New York: Humana Press; 2016. p. 309–29.
Chapter
Google Scholar
Larcher T, Lafoux A, Tesson L, Remy S, Thepenier V, François V. Characterization of dystrophin deficient rats: a new model for Duchenne muscular dystrophy. PLoS One. 2014;9(10):e110371.
Article
PubMed
PubMed Central
CAS
Google Scholar
Kornegay JN, Spurney CF, Nghiem PP, Brinkmeyer-Langford CL, Hoffman EP, Nagaraju K. Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials. ILAR J. 2014;55:119–49.
Article
CAS
PubMed
PubMed Central
Google Scholar
Partridge TA. The mdx mouse model as a surrogate for Duchenne muscular dystrophy. FEBS J. 2013;280:4177–86.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ergorul C, Levin LA. Solving the lost in translation problem: improving the effectiveness of translational research. Curr Opin Pharmacol. 2013;13:108–14.
Article
CAS
PubMed
Google Scholar
Landis SC, Amara SG, Asadullah K, Austin CP, Blumenstein R, Bradley EW, et al. A call for transparent reporting to optimize the predictive value of preclinical research. Nature. 2012;490:187–91.
Article
CAS
PubMed
PubMed Central
Google Scholar
Willmann R, Luca A, Nagaraju K, Rüegg MA. Best practices and standard protocols as a tool to enhance translation for neuromuscular disorders. J Neuromuscul Dis. 2015;14:113–7.
Article
Google Scholar
Cardinet GH, Holliday TA. Neuromuscular diseases of domestic animals: a summary of muscle biopsies from 159 cases. Ann NY Acad Sci. 1979;317:290–313.
Article
PubMed
Google Scholar
Valentine BA, Cooper BJ, Dietze AE, Noden DM. Canine congenital diaphragmatic hernia. J Vet Intern Med. 1988;2:109–12.
Article
CAS
PubMed
Google Scholar
Kornegay JN. Golden retriever myopathy. In: Kirk RW, editor. Current veterinary therapy IX. Philadelphia: WB Saunders Co; 1986. p. 792–4.
Google Scholar
Kornegay JN, Tuler SM, Miller DM, Levesque DC. Muscular dystrophy in a litter of golden retriever dogs. Muscle Nerve. 1988;11:1056–64.
Article
CAS
PubMed
Google Scholar
Valentine BA, Cooper BJ, de Lahunta A, O’Quinn R, Blue JT. Canine X-linked muscular dystrophy. An animal model of Duchenne muscular dystrophy: clinical studies. J Neurol Sci. 1988;88:69–81.
Article
CAS
PubMed
Google Scholar
Valentine BA, Cooper BJ, Cummings JF, de Lahunta A. Canine X-linked muscular dystrophy: morphologic lesions. J Neurol Sci. 1990;97:1–23.
Article
CAS
PubMed
Google Scholar
Meier H. Myopathies in the dog. Cornell Vet. 1958;48:313–30.
CAS
PubMed
Google Scholar
Keijzer R, Puri P. Congenital diaphragmatic hernia. Semin Pediatr Surg. 2010;19:180–5.
Article
PubMed
Google Scholar
Inanlou MR, Kablar B. Abnormal development of the diaphragm in mdx: MyoD-/-(9th) embryos leads to pulmonary hypoplasia. Int J Dev Biol. 2003;47:363–71.
PubMed
Google Scholar
deLahunta A. Veterinary neuroanatomy and clinical neurology. Philadelphia: WB Saunders Co; 1977. p. 84–5.
Google Scholar
Wentink GH, Meijer AE, van der Linde-Sipman JS, Hendriks HJ. Myopathy in an irish terrier with a metabolic defect of the isolated mitochondria. Zentralbl Veterinarmed A. 1974;21:62–74.
Article
CAS
PubMed
Google Scholar
Valentine BA, Cooper BJ, Cummings JF, deLahunta A. Progressive muscular dystrophy in a golden retriever dog: light microscope and ultrastructural features at 4 and 8 months. Acta Neuropathol. 1986;71:301–10.
Article
CAS
PubMed
Google Scholar
Cooper BJ, Winand NJ, Stedman H, Valentine BA, Hoffman EP, Kunkel LM, et al. The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature. 1988;334:154–6.
Article
CAS
PubMed
Google Scholar
Cooper BJ, Valentine BA, Wilson S, Patterson DF, Concannon PW. Canine muscular dystrophy: confirmation of X-linked inheritance. J Hered. 1988;79:405–8.
Article
CAS
PubMed
Google Scholar
Sharp NJ, Kornegay JN, Van Camp SD, Herbstreith MH, Secore SL, Kettle S, et al. An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy. Genomics. 1992;13:115–21.
Article
CAS
PubMed
Google Scholar
Kornegay JN, Bogan JR, Bogan DJ, Childers MK, Li J, Nghiem P, et al. Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies. Mamm Genome. 2012;23:85–108.
Article
CAS
PubMed
PubMed Central
Google Scholar
Smith BF, Yue Y, Woods PR, Kornegay JN, Shin JH, Williams RR, et al. An intronic LINE-1 element insertion in the dystrophin gene aborts dystrophin expression and results in Duchenne-like muscular dystrophy in the corgi breed. Lab Invest. 2011;91:216–31.
Article
CAS
PubMed
Google Scholar
Atencia-Fernandez S, Shiel RE, Mooney CT, Nolan CM. Muscular dystrophy in the Japanese Spitz: an inversion disrupts the DMD and RPGR genes. Anim Genet. 2015;46:175–84.
Article
CAS
PubMed
Google Scholar
Jenkins CA, Forman OP. Identification of a novel frameshift mutation in the DMD gene as the cause of muscular dystrophy in a Norfolk terrier dog. Canine Genet Epidemiol. 2015;2:7.
Article
PubMed
PubMed Central
Google Scholar
Schatzberg SJ, Olby NJ, Breen M, Anderson LV, Langford CF, Dickens HF, et al. Molecular analysis of a spontaneous dystrophin “knockout” dog. Neuromuscul Disord. 1999;9:289–95.
Article
CAS
PubMed
Google Scholar
VanBelzen DJ, Malik AS, Henthorn PS, Kornegay JN, Stedman HH. Mechanism of deletion removing all dystrophin exons in canine model for DMD implicates concerted evolution of X-chromosome pseudogenes. Mol Ther Methods Clin Dev. 2016;24:62–71.
Google Scholar
Walmsley GL, Arechavala-Gomeza V, Fernandez-Fuente M, Burke MM, Nagel N, Holder A, et al. A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping. PLoS One. 2010;5(1):e8647.
Article
PubMed
PubMed Central
CAS
Google Scholar
Nghiem PP, Bello L, Balog C, Mata-López S, Bettis A, Barnett H, et al. Whole genome sequencing reveals a 7 base-pair deletion in DMD exon 42 in a dog with muscular dystrophy. Mamm Genome. 2016.
Winand N, Pradham D, Cooper B. Molecular characterization of severe Duchenne-type muscular dystrophy in a family of Rottweiler dogs. Tucson: Molecular Mechanisms of Neuromuscular Disease, Muscular Dystrophy Association; 1994.
Google Scholar
Schatzberg SJ, Anderson LV, Wilton SD, Kornegay JN, Mann CJ, Solomon GG, et al. Alternative dystrophin gene transcripts in golden retriever muscular dystrophy. Muscle Nerve. 1998;21:991–8.
Article
CAS
PubMed
Google Scholar
Nicholson LV. The “rescue” of dystrophin synthesis in boys with Duchenne muscular dystrophy. Neuromuscul Disord. 1993;3:525–31.
Article
CAS
PubMed
Google Scholar
Nicholson LV, Johnson MA, Bushby KM, Gardner-Medwin D. Functional significance of dystrophin positive fibres in Duchenne muscular dystrophy. Arch Dis Child. 1993;68:632–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Arechavala-Gomeza V, Kinali M, Feng L, Guglieri M, Edge G, Main M, et al. Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: implication for clinical trials. Neuromuscul Disord. 2010;20:295–301.
Article
PubMed
Google Scholar
Baroncelli AB, Abellonio F, Pagano TB, Esposito I, Peirone B, Papparella S, et al. Muscular dystrophy in a dog resembling human becker muscular dystrophy. J Comp Pathol. 2014;150:429–33.
Article
CAS
PubMed
Google Scholar
Vieira NM, Guo LT, Estrela E, Kunkel LM, Zatz M, Shelton GD. Muscular dystrophy in a family of Labrador Retrievers with no muscle dystrophin and a mild phenotype. Neuromuscul Disord. 2015;25:363–70.
Article
PubMed
Google Scholar
Olby NJ, Sharp NJ, Nghiem PE, Keene BW, DeFrancesco TC, Sidley JA, et al. Clinical progression of X-linked muscular dystrophy in two German Shorthaired Pointers. J Am Vet Med Assoc. 2011;238:207–12.
Article
PubMed
Google Scholar
Vieira NM, Elvers I, Alexander MS, Moreira YB, Eran A, Gomes JP, et al. Jagged 1 rescues the Duchenne muscular dystrophy phenotype. Cell. 2015;163:1204–13.
Article
CAS
PubMed
PubMed Central
Google Scholar
Brinkmeyer-Langford C, Balog-Alvarez C, Cai JJ, Davis BW, Kornegay JN. Genome-wide association study to identify potential genetic modifiers in a canine model for Duchenne muscular dystrophy. BMC Genomics. 2016;17:665.
Article
PubMed
PubMed Central
Google Scholar
Shimatsu Y, Katagiri K, Furuta T, Nakura M, Tanioka Y, Yuasa K, et al. Canine X-linked muscular dystrophy in Japan (CXMDJ). Exp Anim. 2003;52:93–7.
Article
CAS
PubMed
Google Scholar
Yokota T, Lu QL, Partridge T, Kobayashi M, Nakamura A, Takeda S, et al. Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs. Ann Neurol. 2009;65:667–76.
Article
PubMed
Google Scholar
Patronek GJ, Waters DJ, Glickman LT. Comparative longevity of pet dogs and humans: implications for gerontology research. J Gerontol A Biol Sci Med Sci. 1997;52:B171–8.
Article
CAS
PubMed
Google Scholar
Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Miller JP, et al. Clinical investigation in Duchenne dystrophy: 2. Determination of the “power” of therapeutic trials based on the natural history. Muscle Nerve. 1983;6:91–103.
Article
CAS
PubMed
Google Scholar
McDonald CM, Abresch RT, Carter GT, Fowler Jr WM, Johnson ER, Kilmer DD, et al. Profiles of neuromuscular diseases. Duchenne muscular dystrophy. Am J Phys Med Rehabil. 1995;74 Suppl 5:70–92.
Article
Google Scholar
Kornegay JN, Bogan JR, Bogan DJ, Childers MK, Grange RW. Golden retriever muscular dystrophy (GRMD): developing and maintaining a colony and physiological functional measurements. Methods Mol Biol. 2011;709:105–23.
Article
CAS
PubMed
Google Scholar
Nigro G. Importance of cardiological studies in the muscular dystrophies. Cardiomyology. 1983;2:209–19.
Google Scholar
Nigro G, Comi LI, Politano L, Bain RJI. The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol. 1990;26:271–7.
Article
CAS
PubMed
Google Scholar
Markham LW, Michelfelder EC, Border WL, Khoury PR, Spicer RL, Wong BL, et al. Abnormalities of diastolic function precede dilated cardiomyopathy associated with Duchenne muscular dystrophy. J Am Soc Echo. 2006;19:865–71.
Article
Google Scholar
Bushby KMD, Hill A, Steele JG. Failure of early diagnosis in symptomatic Duchenne muscular dystrophy. Lancet. 1999;353:557–8.
Article
CAS
PubMed
Google Scholar
Nicholson LV, Johnson MA, Bushby KM, Gardner-Medwin D, Curtis A, Ginjaar IB, et al. Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunocytochemical, and histopathological data. Part 1. Trends across the clinical groups. J Med Genet. 1993;30:728–37.
Article
CAS
PubMed
PubMed Central
Google Scholar
Khirani S, Ramirez A, Aubertin G, Boulé M, Chemouny C, Forin V, et al. Respiratory muscle decline in Duchenne muscular dystrophy. Pediatr Pulmonol. 2014;49:473–81.
Article
PubMed
Google Scholar
Fine DM, Shin JH, Yue Y, Volkmann D, Leach SB, Smith BF, et al. Age-matched comparison reveals early electrocardiography and echocardiography changes in dystrophin-deficient dogs. Neuromuscul Disord. 2011;21:453–61.
Article
PubMed
PubMed Central
Google Scholar
Moise NS, Valentine BA, Brown CA, Erb HN, Beck KA, Cooper BJ, et al. Duchenne’s cardiomyopathy in a canine model: electrocardiographic and echocardiographic studies. J Am Coll Cardiol. 1991;17:812–20.
Article
CAS
PubMed
Google Scholar
Nakamura A, Kobayashi M, Kuraoka M, Yuasa K, Yugeta N, Okada T, et al. Initial pulmonary respiration causes massive diaphragm damage and hyper-CKemia in Duchenne muscular dystrophy dog. Sci Rep. 2013;3:2183.
Article
PubMed
PubMed Central
Google Scholar
Kornegay JN, Bogan DJ, Bogan JR, Childers MK, Cundiff DD, Petroski GF, et al. Contraction force generated by tibiotarsal joint flexion and extension in dogs with golden retriever muscular dystrophy. J Neurol Sci. 1999;166:115–21.
Article
CAS
PubMed
Google Scholar
Barthélémy I, Pinto-Mariz F, Yada E, Desquilbet L, Savino W, Silva-Barbosa SD, et al. Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy. Dis Model Mech. 2014;7:1253–61.
Article
PubMed
PubMed Central
CAS
Google Scholar
Bello L, Kesari A, Gordish-Dressman H, Cnaan A, Morgenroth LP, Punetha J, et al. Genetic modifiers of ambulation in the cooperative international Neuromuscular research group Duchenne natural history study. Ann Neurol. 2015;77:684–96.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu JM, Okamura CS, Bogan DJ, Bogan JR, Childers MK, Kornegay JN. Effects of prednisone in canine muscular dystrophy. Muscle Nerve. 2004;30:767–73.
Article
PubMed
Google Scholar
Acosta AR, Van Wie E, Stoughton WB, Bettis AK, Barnett HH, LaBrie NR, et al. Use of the six-minute walk test to characterize golden retriever muscular dystrophy. Neuromuscul Disord. 2016;26:865–72.
Article
PubMed
Google Scholar
Kornegay JN, Peterson JM, Bogan DJ, Kline W, Bogan JR, Dow JL, et al. NBD delivery improves the disease phenotype of the golden retriever model of Duchenne muscular dystrophy. Skelet Muscle. 2014;4:18.
Article
PubMed
PubMed Central
CAS
Google Scholar
Edwards RHT, Jones DA, Newham DJ, Chapman SJ. Role of mechanical damage in the pathogenesis of proximal myopathy in man. Lancet. 1984;1(8376):548–52.
Article
CAS
PubMed
Google Scholar
Barthélémy I, Uriarte A, Drougard C, Unterfinger Y, Thibaud JL, Blot S. Effects of an immunosuppressive treatment in the GRMD dog model of Duchenne muscular dystrophy. PLoS One. 2012;7:e48478.
Article
PubMed
PubMed Central
CAS
Google Scholar
Galindo CL, Soslow JH, Brinkmeyer-Langford CL, Gupte M, Smith HM, Sengsayadeth S, et al. Translating golden retriever muscular dystrophy microarray findings to novel biomarkers for cardiac/skeletal muscle function in Duchenne muscular dystrophy. Pediatr Res. 2016;79:629–36.
Article
CAS
PubMed
Google Scholar
Nghiem PP, Hoffman EP, Mittal P, Brown KJ, Schatzberg SJ, Ghimbovschi S, et al. Sparing of the dystrophin-deficient cranial sartorius muscle is associated with classical and novel hypertrophy pathways in GRMD dogs. Am J Pathol. 2013;183:1411–24.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gloss D, Moxley 3rd RT, Ashwal S, Oskoui M. Practice guideline update summary: corticosteroid treatment of Duchenne muscular dystrophy: Report of the Guideline Development subcommittee of the American Academy of Neurology. Neurology. 2016;86:465–72.
Article
CAS
PubMed
PubMed Central
Google Scholar
Matthews E, Brassington R, Kuntzer T, Jichi F, Manzur AY. Corticosteroids for the treatment of Duchenne muscular dystrophy. Cochrane Database Syst Rev. 2016;5:CD003725.
Google Scholar
Connolly AM, Schierbecker J, Renna R, Florence J. High dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy. Neuromuscul Disord. 2001;12:917–25.
Article
Google Scholar
Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008;22:659–61.
Article
CAS
PubMed
Google Scholar
Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science. 1995;270:286–90.
Article
CAS
PubMed
Google Scholar
Monici MC, Aguennouz M, Mazzeo A, Messina C, Vita G. Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy. Neurology. 2003;60:993–7.
Article
CAS
PubMed
Google Scholar
Gazzerro E, Assereto S, Bonetto A, Sotgia F, Scarfì S, Pistorio A, et al. Therapeutic potential of proteasome inhibition in Duchenne and Becker muscular dystrophies. Am J Pathol. 2010;176:1863–77.
Article
CAS
PubMed
PubMed Central
Google Scholar
Briguet A, Erb M, Courdier-Fruh I, Barzaghi P, Santos G, Herzner H, et al. Effect of calpain and proteasome inhibition on Ca2+-dependent proteolysis and muscle histopathology in the mdx mouse. FASEB J. 2008;22:4190–200.
Article
CAS
PubMed
Google Scholar
Wadosky KM, Li L, Rodríguez JE, Min J, Bogan D, Gonzalez J, et al. Regulation of the calpain and ubiquitin proteasome systems in a canine model of Duchenne muscular dystrophy. Muscle Nerve. 2011;44:553–62.
Article
CAS
PubMed
PubMed Central
Google Scholar
Childers MK, Bogan JR, Bogan DJ, Greiner H, Holder M, Grange RW, et al. Chronic administration of a leupeptin-derived calpain inhibitor fails to ameliorate severe muscle pathology in a canine model of duchenne muscular dystrophy. Front Pharmacol. 2012;2:89.
Article
PubMed
PubMed Central
Google Scholar
McPherron AC, Lawler AM, Lee S-J. Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature. 1997;387:83–90.
Article
CAS
PubMed
Google Scholar
Lee S-J. Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol. 2004;20:61–86.
Article
CAS
PubMed
Google Scholar
Wagner KR, McPherron AC, Winik N, Lee SJ. Loss of myostatin attenuates severity of muscular dystrophy in mdx mice. Ann Neurol. 2002;52:832–6.
Article
CAS
PubMed
Google Scholar
Wagner KR, Liu X, Chang X, Allen RE. Muscle regeneration in the prolonged absence of myostatin. Proc Natl Acad Sci U S A. 2005;102:2519–24.
Article
CAS
PubMed
PubMed Central
Google Scholar
Qiao C, Li J, Zheng H, Bogan J, Li J, Yuan Z, et al. Hydrodynamic limb vein injection of adeno-associated virus serotype 8 vector carrying canine myostatin propeptide gene into normal dogs enhances muscle growth. Hum Gene Ther. 2009;20:1–10.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bish LT, Sleeper MM, Forbes SC, Morine KJ, Reynolds C, Singletary GE, et al. Long-term systemic myostatin inhibition via liver-targeted gene transfer in golden retriever muscular dystrophy. Hum Gene Ther. 2011;22:1499–509.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen Y-W, Nagaraju K, Bakay M, McIntyre O, Rawat R, Shi R, et al. Early onset of inflammation and later involvement of TGFβ in Duchenne muscular dystrophy. Neurology. 2005;65:826–34.
Article
CAS
PubMed
Google Scholar
Tseng BS, Zhao P, Pattison JS, Gordon SE, Granchelli JA, Madsen RW, et al. Regenerated mdx mouse skeletal muscle shows differential mRNA expression. J Appl Physiol. 2002;93:537–45.
Article
CAS
PubMed
Google Scholar
Kornegay JN, Bogan DJ, Bogan JR, Dow JL, Wang J, Fan Z, et al. Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures. Skelet Muscle. 2016;6:14.
Article
PubMed
PubMed Central
CAS
Google Scholar
Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature. 1989;337:176–9.
Article
CAS
PubMed
Google Scholar
Tremblay JP, Malouin F, Roy R, Huard J, Bouchard JP, Satoh A, et al. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant. 1993;2:99–112.
CAS
PubMed
Google Scholar
Miller RG, Sharma KR, Pavlath GK, Gussoni E, Mynhier M, Yu P, et al. Myoblast transplantation in Duchenne muscular dystrophy: the San Francisco study. Muscle Nerve. 1997;20:469–78.
Article
CAS
PubMed
Google Scholar
Partridge T. Myoblast transplantation. Neuromuscul Disord. 2002;12 Suppl 1:3–6.
Article
Google Scholar
Smythe GM, Hodgetts SI, Grounds MD. Problems and solutions in myoblast transfer therapy. J Cell Mol Med. 2001;5:33–47.
Article
CAS
PubMed
Google Scholar
Skuk D, Paradis M, Goulet M, Tremblay JP. Ischemic central necrosis in pockets of transplanted myoblasts in nonhuman primates: implications for cell-transplantation strategies. Transplantation. 2007;84:1307–15.
Article
PubMed
Google Scholar
Prattis SM, Horton SB, Van Camp SD, Kornegay JN. Immunohistochemical detection of neural cell adhesion molecule and laminin in X-linked dystrophic dogs and mdx mice. J Comp Pathol. 1994;110:253–66.
Article
CAS
PubMed
Google Scholar
Kornegay JN, Prattis SM, Bogan DJ, Sharp NJH, Bartlett RJ, Alameddine HS, et al. Results of myoblast transplantation in a canine model of muscle injury. In: Kakulas BA, Mc HJ, Roses AD, editors. Duchenne muscular dystrophy. Animal models and genetic manipulation. San Diego: Raven; 1992. p. 203–12.
Google Scholar
Gussoni E, Soneoka Y, Strickland CD, Buzney EA, Khan MK, Flint AF, et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature. 1999;401:390–4.
CAS
PubMed
Google Scholar
Gussoni E, Bennett RR, Muskiewicz KR, Meyerrose T, Nolta JA, Gilgoff I, et al. Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation. J Clin Invest. 2002;110:807–14.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ferrari G, Stornaiuolo A, Mavilio F. Failure to correct murine muscular dystrophy. Nature. 2001;411:1014–5.
Article
CAS
PubMed
Google Scholar
Storb R, Thomas ED. Graft-versus-host disease in dog and man: the Seattle experience. Immunol Rev. 1985;88:215–38.
Article
CAS
PubMed
Google Scholar
Dell’Agnola C, Wang Z, Storb R, Tapscott SJ, Kuhr CS, Hauschka SD, et al. Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs. Blood. 2004;104:4311–8.
Article
PubMed
CAS
Google Scholar
Loperfido M, Jarmin S, Dastidar S, Di Matteo M, Perini I, Moore M, et al. piggyBac transposons expressing full-length human dystrophin enable genetic correction of dystrophic mesoangioblasts. Nucleic Acids Res. 2016;44:744–60.
Article
CAS
PubMed
Google Scholar
Pelatti MV, Gomes JP, Vieira NM, Cangussu E, Landini V, Andrade T, et al. Transplantation of human adipose mesenchymal stem cells in non-immunosuppressed GRMD dogs is a safe procedure. Stem Cell Rev. 2016;12:448–53.
Article
CAS
PubMed
Google Scholar
Robriquet F, Babarit C, Larcher T, Dubreil L, Ledevin M, Goubin H, et al. Identification in GRMD dog muscle of critical miRNAs involved in pathophysiology and effects associated with MuStem cell transplantation. BMC Musculoskelet Disord. 2016;17:209.
Article
PubMed
PubMed Central
CAS
Google Scholar
Skuk D, Tremblay JP. Cell therapy in muscular dystrophies: many promises in mice and dogs, few facts in patients. Expert Opin Biol Ther. 2015;15:1307–19.
Article
PubMed
CAS
Google Scholar
Boulanger A, Asselin I, Roy R, Tremblay JP. Role of non-major histocompatibility complex antigens in the rejection of transplanted myoblasts. Transplantation. 1997;63:893–9.
Article
CAS
PubMed
Google Scholar
Sampaolesi M, Blot S, D’Antona G, Granger N, Tonlorenzi R, Innocenzi A, et al. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature. 2006;444:574–9.
Article
CAS
PubMed
Google Scholar
Davies KE, Grounds MD. Treating muscular dystrophy with stem cells? Cell. 2006;127:1304–6.
Article
CAS
PubMed
Google Scholar
Rouger K, Larcher T, Dubreil L, Deschamps JY, Le Guiner C, Jouvion G, et al. Systemic delivery of allogenic muscle stem (MuStem) cells Induces long-term muscle repair and clinical efficacy in Duchenne muscular dystrophy dogs. Am J Pathol. 2011;179:2501–18.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zucconi E, Vieira NM, Bueno Jr CR, Secco M, Jazedje T, CostaValadares M, et al. Preclinical studies with umbilical cord mesenchymal stromal cells in different animal models for muscular dystrophy. J Biomed Biotechnol. 2011;2011:715251.
Article
PubMed
PubMed Central
CAS
Google Scholar
Vieira NM, Valadares M, Zucconi E, Secco M, Bueno Jr CR, et al. Human adipose-derived mesenchymal stromal cells injected systemically into GRMD dogs without immunosuppression are able to reach the host muscle and express human dystrophin. Cell Transplant. 2012;21:1407–17.
Article
CAS
PubMed
Google Scholar
Sitzia C, Farini A, Jardim L, Razini P, Belicchi M, Cassinelli L, et al. Adaptive immune response impairs the efficacy of autologous transplantation of engineered stem cells in dystrophic dogs. Mol Ther. 2016;24(11):1949–64.
Article
CAS
PubMed
Google Scholar
Yokota T, Nakamura A, Nagata T, Saito T, Kobayashi M, Aoki Y, et al. Extensive and prolonged restoration of dystrophin expression with vivo-morpholino-mediated multiple exon skipping in dystrophic dogs. Nucleic Acid Ther. 2012;22:306–15.
CAS
PubMed
PubMed Central
Google Scholar
Vulin A, Barthélémy I, Goyenvalle A, Thibaud JL, Beley C, Griffith G, et al. Muscle function recovery in golden retriever muscular dystrophy after AAV1-U7 exon skipping. Mol Ther. 2012;20:2120–33.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bish LT, Sleeper MM, Forbes SC, Wang B, Reynolds C, Singletary GE, et al. Long-term restoration of cardiac dystrophin expression in golden retriever muscular dystrophy following rAAV6-mediated exon skipping. Mol Ther. 2012;20:580–9.
Article
CAS
PubMed
Google Scholar
Le Guiner C, Montus M, Servais L, Cherel Y, Francois V, Thibaud JL, et al. Forelimb treatment in a large cohort of dystrophic dogs supports delivery of a recombinant AAV for exon skipping in Duchenne patients. Mol Ther. 2014;22:1923–35.
Article
PubMed
PubMed Central
CAS
Google Scholar
Wang Z, Allen JM, Riddell SR, Gregorevic P, Storb R, Tapscott SJ, et al. Immunity to adeno-associated virus-mediated gene transfer in a random-bred canine model of Duchenne muscular dystrophy. Hum Gene Ther. 2007;18:18–26.
Article
PubMed
CAS
Google Scholar
Yuasa K, Yoshimura M, Urasawa N, Ohshima S, Howell JM, Nakamura A, et al. Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products. Gene Ther. 2007;14:1249–60.
Article
CAS
PubMed
Google Scholar
Wang Z, Kuhr CS, Allen JM, Blankenship M, Gregorevic P, Chamberlain JS, et al. Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression. Mol Ther. 2007;15:1160–6.
Article
CAS
PubMed
Google Scholar
Koo T, Okada T, Athanasopoulos T, Foster H, Takeda S, Dickson G. Long-term functional adeno-associated virus-microdystrophin expression in the dystrophic CXMDj dog. J Gene Med. 2011;13:497–506.
Article
CAS
PubMed
Google Scholar
Shin JH, Pan X, Hakim CH, Yang HT, Yue Y, Zhang K, et al. Microdystrophin ameliorates muscular dystrophy in the canine model of duchenne muscular dystrophy. Mol Ther. 2013;21:750–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fan Z, Kocis K, Valley R, Howard JF, Chopra M, An H, et al. Safety and feasibility of high-pressure transvenous limb perfusion with 0.9% saline in human muscular dystrophy. Mol Ther. 2012;20:456–61.
Article
PubMed
CAS
Google Scholar
Fan Z, Kocis K, Valley R, Howard Jr JF, Chopra M, Chen Y, et al. High-pressure transvenous perfusion of the upper extremity in human muscular dystrophy: a safety study with 0.9% saline. Hum Gene Ther. 2015;26:614–21.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yue Y, Pan X, Hakim CH, Kodippili K, Zhang K, Shin JH, et al. Safe and bodywide muscle transduction in young adult Duchenne muscular dystrophy dogs with adeno-associated virus. Hum Mol Genet. 2015;15:5880–90.
Kornegay JN, Li J, Bogan JR, Bogan DJ, Chen C, Zheng H, et al. Widespread muscle expression of an AAV9 human mini-dystrophin vector after intravenous injection in neonatal dystrophin-deficient dogs. Mol Ther. 2010;18:1501–8.
Article
CAS
PubMed
PubMed Central
Google Scholar